PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 153 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $167,000 | -80.4% | 32,956 | -76.2% | 0.10% | -79.9% |
| Q2 2019 | $853,000 | +33.1% | 138,357 | 0.0% | 0.47% | +32.2% |
| Q1 2019 | $641,000 | +101.6% | 138,357 | +81.6% | 0.36% | +48.1% |
| Q4 2018 | $318,000 | +238.3% | 76,200 | +408.0% | 0.24% | +239.4% |
| Q3 2018 | $94,000 | – | 15,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |